by The global clinical nutrition market size was estimated at around USD 30.68 billion in 2023 and it is projected to hit around USD 51.76 billion by 2033, growing at a CAGR of 5.37% from 2024 to 2033.
Clinical Nutrition Market Overview
The clinical nutrition market includes a diverse range of products and services designed to meet the nutritional needs of patients with particular medical conditions or those undergoing medical treatments. This sector of the healthcare industry is essential for aiding individuals who may struggle to fulfill their nutritional requirements solely through regular diet, often due to illness, surgery, or other medical interventions.
Clinical Nutrition Market Trends:
- Focus on Nutraceuticals and Functional Foods: Nutraceuticals and functional foods, which offer health benefits beyond basic nutrition, are gaining popularity in the clinical nutrition market. Manufacturers are developing products fortified with bioactive compounds, vitamins, and minerals to address specific health conditions and promote overall well-being.
- Emphasis on Sustainable Packaging: With increasing awareness of environmental sustainability, there is a growing emphasis on sustainable packaging solutions within the clinical nutrition market. Manufacturers are exploring eco-friendly packaging materials, recyclable packaging options, and reducing plastic usage to minimize environmental impact.
- Expansion of Home Healthcare Services: The rise of home healthcare services is driving demand for portable and convenient nutritional products that can be administered outside of traditional healthcare settings. This includes the development of compact, ready-to-use nutritional solutions and meal replacement options for patients receiving home-based medical care.
Get a Sample@ https://www.visionresearchreports.com/report/sample/41229
Product Insights
In 2023, the global oral clinical nutrition market took the lead, capturing a significant share of 54%. This dominance is fueled by various factors, including the increasing prevalence of malnutrition in adults and the rise in conditions such as obesity, cancer, and diabetes. Market leaders and innovators are actively introducing new products aimed at improving productivity, durability, and quality, while also enhancing nutritional content and taste. As a result, there’s a noticeable surge in demand for oral clinical nutrition products worldwide. For example, in March 2021, Kate Farms introduced two new products, Kate Farms Standard 1.4 Vanilla and Plain, and Kate Farms Pediatric Peptide Vanilla Flavor 1.0, designed to address nutrient deficiencies in patients with chronic conditions such as allergies, malnutrition, cancer, and gastrointestinal disorders. These innovative product launches are expected to further drive industry growth.
Moreover, the parenteral nutrition segment is projected to witness the fastest Compound Annual Growth Rate (CAGR) during the forecasted period. This growth is attributed to advancements in technically advanced parenteral nutrition (PN) products equipped with barcode assistance. Additionally, factors like the increasing preference for PN over enteral nutrition among patients, shorter hospital stays, and reduced risk of infection contribute to the heightened demand, thereby driving market expansion.
Indication Insights
In 2023, the cancer care segment accounted for 19% of global revenue. The primary driver behind the growth of this segment is the rising prevalence of cancer worldwide. According to the Pan American Health Organization, North America alone witnessed approximately 4 million new cancer cases in 2020, leading to 1.4 million deaths. Similarly, data from the American Cancer Society Journal in January 2023 projected around 609,820 cancer-related deaths in the U.S. for the same year. Furthermore, projections suggest a significant increase in global cancer cases by 2040, with an estimated 30 million new cases, particularly in low- and middle-income countries. These statistics highlight the pressing need for comprehensive strategies to address the growing burden of cancer and provide essential support to affected populations worldwide.
Additionally, the Malabsorption/GI Disorder/Diarrhea segment is expected to experience the fastest growth rate over the forecast period. Malabsorption, characterized by difficulty digesting nutrients from food, is associated with conditions such as short bowel syndrome, cystic fibrosis, chronic pancreatitis, and Crohn’s disease. Without adequate nutrients, malabsorption can lead to further health complications. Enteral nutrition, administered orally or through tube feeding, plays a critical role in supplying necessary nutrients and enhancing gut immunity. Various enteral feeds are available to address malabsorption, such as Abbott’s Vital peptide 1.5 Cal, which offers a therapeutic formulation beneficial for managing malabsorption and gastrointestinal disorders.
Sales Channel Insights
In 2023, the institutional sales channel dominated the market with the largest share, accounting for 46%. Institutions that purchase clinical nutrition products include hospitals, long-term care centers, hospices, and disability facilities. The decision to procure enteral or parenteral nutrition products is heavily influenced by medical professionals, particularly doctors. The growth of this segment is further driven by the growing number of both private and public institutions and the expanding population of patients with chronic diseases worldwide.
On the contrary, the online sales channel segment is poised for the fastest growth. There’s a noticeable trend towards direct selling to consumers through e-commerce platforms. The preference for purchasing enteral feeding formula online is increasing due to the convenience offered by this sales channel. Despite being consumed under medical supervision, these products are primarily intended for long-term nutrition management, thus contributing to the rising sales through e-commerce platforms.
Regional Insights
In 2023, North America emerged as the leading force in the global clinical nutrition market, capturing a significant 33% share. This growth is primarily driven by the increasing elderly population in the region, which is more prone to various chronic diseases like gastrointestinal disorders, metabolic disorders, and neurological conditions. According to data from the United Health Foundation, in 2022, approximately 17.3% of the U.S. population was aged 65 and above. Projections indicate that by 2030, around 56 million elderly individuals in the U.S. will rely on clinical nutrition to fulfill their nutritional needs.
The clinical nutrition market in the Asia Pacific region is poised for substantial expansion. This expected growth is fueled by several factors, including the region’s large patient population and aging demographic. Lifestyle changes also contribute to an increase in the prevalence of various diseases such as cancer, diabetes, gastrointestinal disorders, and autoimmune conditions. Consequently, there’s a rising demand for clinical nutrition solutions to aid in the dietary management of these chronic diseases.
Read More: https://www.heathcareinsights.com/u-s-long-term-care-private-insurance-market/
Clinical Nutrition Market Key Companies
- Abbott Nutrition
- Pfizer Inc.
- Bayer AG
- Nestle
- Baxter International Inc.
- Otsuka Holdings Co., Ltd.
- Mead Johnson & Company, LLC
- Danone (Nutricia)
- Victus, Inc.
- Fresenius Kabi
- Meiji Holdings. Co., Ltd.
- Abbvie (Allergan)
- Baxter
- Grifols, S.A.
Clinical Nutrition Market Segmentations:
By Product
- Oral Clinical Nutrition
- Parenteral Nutrition
- Carbohydrates
- Parenteral Lipid Emulsion
- Single Dose Amino Acid Solutions
- Trace Elements
- Vitamins & Minerals
- Enteral Feeding Formulas
- Standard Formula
- Disease-specific Formulas
By Indication
- Alzheimer’s
- Nutrition Deficiency
- Cancer Care
- Diabetes
- Chronic Kidney Diseases
- Orphan Diseases
- Dysphagia
- Pain Management
- Malabsorption/GI Disorder/Diarrhea
- Others
By Sales Channel
- Retail Sales Channels
- Online Sales Channels
- Institutional Sales Channels
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Buy this Premium Research Report@ https://www.visionresearchreports.com/report/checkout/41229
You can place an order or ask any questions, please feel free to contact sales@visionresearchreports.com| +1 650-460-3308
